Labcorp Holdings Inc. (BMV:LH)

Market Cap	390.35B -6.2%
Revenue (ttm)	252.49B +8.3%
Net Income	15.69B +96.4%
EPS	186.85 +98.4%
Shares Out	n/a
PE Ratio	24.88
Forward PE	15.83
Dividend	55.42 (1.18%)
Ex-Dividend Date	Nov 26, 2025

Volume	82
Average Volume	305
Open	4,705.14
Previous Close	n/a
Day's Range	4,705.14 - 4,705.14
52-Week Range	4,509.76 - 5,336.44
Beta	0.97
RSI	51.34
Earnings Date	Feb 17, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: LH

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD